| abstract |
The invention relates to compounds of formula I having antitumor activities by inhibiting heat shock protein 90 (Hsp90) as a molecular chaperone, as one of the possible biological targets. The invention includes the use of such compounds in medicine for a malignant tumor, as well as other diseases that respond to inhibition of Hsp90, and a pharmaceutical composition containing such compounds. |